• Our Offering
    • small molecules

      • Preclinical Services
      • IND/Clinical Supply
      • Drug Substance
      • API
      • Advanced Intermediate
      • Highly Potent API
      • ADC Payload
      • Solid Form Services
      • Drug Product
      • Particle Engineering
      • Bioavailability Enhancement
      • Oral Solid
      • Inhalation
      • Parenteral
    • biologics

      • Preclinical Offering
      • Expression Technologies
      • Discovery Services
      • Drug Substance
      • Mammalian
      • Microbial
      • ADCs / Bioconjugates
      • Ibex® Solutions
      • Drug Product
      • Parenteral
    • cell & gene

      • Allogeneic Cell Therapy
      • iPSC Manufacturing
      • Exosomes
      • Cell Based Immunotherapies
      • Autologous Cell Therapy
      • Cell Based Immunotherapies
      • Viral Vectors
      • Services
      • Process Development
      • cGMP Manufacturing
      • Regulatory Support
      • Tissue Acquisition
      • Products
      • Cocoon® Platform
    • bioscience

      • Primary & Stem Cells
      • Bioprocessing Media
      • CellBio Services
      • Culture Media & Reagents
      • ADME & Toxicology
      • Transfection
      • Cell Assays & Analysis
      • Electrophoresis
      • Informatics – Paperless Solutions
      • QC & Endotoxin Detection
      • Automated Sterile Sampling
    • capsules

      • Immediate Release
      • Modified Release
      • Vegetarian
      • Inhalation
      • Over the Counter (OTC)
      • IND / Clinical Supply
      • Equipment
  • Resources
      • technologies & products

        We develop proprietary technology and licensing partnerships to ensure you have access to best-in-class solutions that add value to your own science.

      • regulatory support

        In close collaboration with you, Lonza Regulatory Affairs provide a CMC dossier suitable to the stage of clinical development of your product manufactured by Lonza.

      • technical support

        The collective expertise of our multi-disciplinary team in protein expression and production processes can help you get the most from our industry-leading technologies.

      • knowledge center

        Gather additional industry and technical information from our repository of resources and educational content.

  • About Us
      • about us

        Delivering the medicines of tomorrow today

      • careers

        Find opportunities

      • news

        View press releases

      • locations

        View our locations

      • events

        the next conversation...

      • meet our experts

  • Contact Us
Our Offering
small molecules
  • Preclinical Services
  • IND/Clinical Supply
  • Drug Substance
  • API
  • Advanced Intermediate
  • Highly Potent API
  • ADC Payload
  • Solid Form Services
  • Drug Product
  • Particle Engineering
  • Bioavailability Enhancement
  • Oral Solid
  • Inhalation
  • Parenteral
biologics
  • Preclinical Offering
  • Expression Technologies
  • Discovery Services
  • Drug Substance
  • Mammalian
  • Microbial
  • ADCs / Bioconjugates
  • Ibex® Solutions
  • Drug Product
  • Parenteral
cell & gene
  • Allogeneic Cell Therapy
  • iPSC Manufacturing
  • Exosomes
  • Cell Based Immunotherapies
  • Autologous Cell Therapy
  • Cell Based Immunotherapies
  • Viral Vectors
  • Services
  • Process Development
  • cGMP Manufacturing
  • Regulatory Support
  • Tissue Acquisition
  • Products
  • Cocoon® Platform
bioscience
  • Primary & Stem Cells
  • Bioprocessing Media
  • CellBio Services
  • Culture Media & Reagents
  • ADME & Toxicology
  • Transfection
  • Cell Assays & Analysis
  • Electrophoresis
  • Informatics – Paperless Solutions
  • QC & Endotoxin Detection
  • Automated Sterile Sampling
capsules
  • Immediate Release
  • Modified Release
  • Vegetarian
  • Inhalation
  • Over the Counter (OTC)
  • IND / Clinical Supply
  • Equipment
Resources
technologies & products
regulatory support
technical support
knowledge center
About Us
about us
careers
news
locations
events
meet our experts
Contact Us

Our latest news and announcements

    • Knowledge Center
    • Offerings
    • About Us
    • Technologies & Products
    • Contact us
  • About Us
    • Locations
    • Job search
    • Events
  • News
Filter by News Category
General (5) New Technologies (5) Partnerships (1)
Filter by Market
Pharma and Biotech (5) Corporate (2)
Filter by Year
2021 (1) 2020 (4)
Filter by Language
English (5)
New TechnologiesX
EnglishX
Showing 1‐5 of 5
results per page
16 Feb 2021
Lonza Expands Solid Form Services for Small Molecule Drugs
Solid Form Services encompass all aspects of solid form screening and characterization of small molecule APIsOffering designed to complement Lonza...
30 Nov 2020
Lonza Expands Development and Manufacturing Capabilities at Bend (OR) Site
Investment in dedicated early-phase development and cGMP manufacturing in Lonza BendThe first suite on-line by December 2020 will focus on...
18 Nov 2020
Lonza Expands Highly Potent Drug Product Development and Manufacturing Capabilities
Highly potent capability implemented in Lonza-Tampa (US) product development labsHighly potent capable Gerteis roller compactor installed for...
05 Nov 2020
Lonza Celebrates the Grand Opening of a New Facility for ADC Payload Manufacturing
The first manufacturing suite at the Visp (CH) site is dedicated to the manufacturing of antibody-drug conjugate drug-linker and complementary to...
01 Jul 2020
Lonza Expands Particle Engineering Services
Lonza doubles the network jet-milling capacity for supporting development stage projects and expands the capabilities in specialized cGMP...
About Us
  • Careers
  • Events
  • Locations
  • News
Resources
  • Knowledge Center
  • Technologies and Products
  • Technical Support
  • Regulatory Support
Terms
  • Legal Disclaimer
  • Privacy Policy
  • Sitemap
www.lonza.com
© 2021 Lonza. All Rights Reserved.
By visiting our website or using services provided by Lonza, you are accepting the practices described in the Privacy and Cookie policies.